Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Systemic Aspergillosis and Systemic Candidasis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Systemic Aspergillosis and Systemic Candidasismarket, defines the market attractiveness level of Systemic Aspergillosis and Systemic Candidasis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Systemic Aspergillosis and Systemic Candidasis industry, describes the types of Systemic Aspergillosis and Systemic Candidasis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Systemic Aspergillosis and Systemic Candidasis market and the development prospects and opportunities of Systemic Aspergillosis and Systemic Candidasis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Systemic Aspergillosis and Systemic Candidasis market in Chapter 13.
By Player:
Bayer AG
Merck & Co, Inc
GlaxoSmithKline plc
Enzon Pharmaceuticals, Inc
Sanofi-Aventis
Astellas Pharma, Inc
Abbott
Pfizer, Inc
Novartis AG
By Type:
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Other
By End-User:
CPA
ABPA
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Systemic Aspergillosis and Systemic Candidasis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Systemic Aspergillosis and Systemic Candidasis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Systemic Aspergillosis and Systemic Candidasis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Systemic Aspergillosis and Systemic Candidasis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Systemic Aspergillosis and Systemic Candidasis Market Analysis and Outlook to 2022
-
7.1 Global Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.2 United States Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.3 Europe Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.4 China Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.5 Japan Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.6 India Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
-
7.7 South Korea Systemic Aspergillosis and Systemic Candidasis Consumption (2017-2022)
8 Region and Country-wise Systemic Aspergillosis and Systemic Candidasis Market Analysis and Outlook to 2028
-
8.1 Global Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.2 United States Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.3 Europe Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.4 China Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.5 Japan Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.6 India Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
-
8.7 South Korea Systemic Aspergillosis and Systemic Candidasis Consumption Forecast (2022-2028)
9 Global Systemic Aspergillosis and Systemic Candidasis Market Outlook by Types and Applications to 2022
-
9.1 Global Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Voriconazole Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Liposomal Amphotericin B Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Systemic Oral Azoles Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Topical Antifungal Agents Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CPA Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ABPA Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Candidiasis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Genitourinary Tract Candidiasis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Global Systemic Aspergillosis and Systemic Candidasis Market Outlook by Types and Applications to 2028
-
10.1 Global Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Voriconazole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Liposomal Amphotericin B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Systemic Oral Azoles Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Topical Antifungal Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global CPA Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ABPA Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastrointestinal Candidiasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Genitourinary Tract Candidiasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Systemic Aspergillosis and Systemic Candidasis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Systemic Aspergillosis and Systemic Candidasis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Systemic Aspergillosis and Systemic Candidasis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Systemic Aspergillosis and Systemic Candidasis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Systemic Aspergillosis and Systemic Candidasis Market Competitive Analysis
-
14.1 Bayer AG
-
14.1.1 Bayer AG Company Details
-
14.1.2 Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer AG Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.2 Merck & Co, Inc
-
14.2.1 Merck & Co, Inc Company Details
-
14.2.2 Merck & Co, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Details
-
14.3.2 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.4 Enzon Pharmaceuticals, Inc
-
14.4.1 Enzon Pharmaceuticals, Inc Company Details
-
14.4.2 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.5 Sanofi-Aventis
-
14.5.1 Sanofi-Aventis Company Details
-
14.5.2 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.6 Astellas Pharma, Inc
-
14.6.1 Astellas Pharma, Inc Company Details
-
14.6.2 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.7 Abbott
-
14.7.1 Abbott Company Details
-
14.7.2 Abbott Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.8 Pfizer, Inc
-
14.8.1 Pfizer, Inc Company Details
-
14.8.2 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Systemic Aspergillosis and Systemic Candidasis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Systemic Aspergillosis and Systemic Candidasis
-
Figure Systemic Aspergillosis and Systemic Candidasis Picture
-
Table Global Systemic Aspergillosis and Systemic Candidasis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Systemic Aspergillosis and Systemic Candidasis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Systemic Aspergillosis and Systemic Candidasis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Systemic Aspergillosis and Systemic Candidasis Consumption by Country (2017-2022)
-
Figure United States Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Table Europe Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Figure China Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Figure Japan Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Figure India Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Systemic Aspergillosis and Systemic Candidasis Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Aspergillosis and Systemic Candidasis Consumption Forecast by Country (2022-2028)
-
Figure United States Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Systemic Aspergillosis and Systemic Candidasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Voriconazole Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Amphotericin B Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Oral Azoles Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Antifungal Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global CPA Consumption and Growth Rate (2017-2022)
-
Figure Global ABPA Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Candidiasis Consumption and Growth Rate (2017-2022)
-
Figure Global Genitourinary Tract Candidiasis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Voriconazole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Amphotericin B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Oral Azoles Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Antifungal Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CPA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ABPA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Candidiasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genitourinary Tract Candidiasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Systemic Aspergillosis and Systemic Candidasis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Systemic Aspergillosis and Systemic Candidasis Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Enzon Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Astellas Pharma, Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Systemic Aspergillosis and Systemic Candidasis Product and Service
-
